Login / Signup

Stopping Disease-Modifying Treatments in Multiple Sclerosis: A Systematic Review and Meta-Analysis of Real-World Studies.

Luca ProsperiniShalom HaggiagSerena RuggieriCarla TortorellaClaudio Gasperini
Published in: CNS drugs (2023)
Based on our quantitative synthesis of real-world data, in the absence of definitive answers from clinical trials, DMT discontinuation appears feasible with a high degree of certainty in selected patients. While our findings are robust regarding relapse events, future efforts are warranted to determine if DMT discontinuation is associated with isolated disability accrual.
Keyphrases